The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure

Herpesvirus DNA packaging involves binding and cleavage of DNA containing the specific DNA-packaging motifs. Here we report a first characterization of the terminase subunits pUL56 and pUL89 of human cytomegalovirus (HCMV). Both gene products were shown to have comparable nuclease activities in vitr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nucleic acids research 2002-04, Vol.30 (7), p.1695-1703
Hauptverfasser: Scheffczik, Hanno, Savva, Christos G. W., Holzenburg, Andreas, Kolesnikova, Larissa, Bogner, Elke
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1703
container_issue 7
container_start_page 1695
container_title Nucleic acids research
container_volume 30
creator Scheffczik, Hanno
Savva, Christos G. W.
Holzenburg, Andreas
Kolesnikova, Larissa
Bogner, Elke
description Herpesvirus DNA packaging involves binding and cleavage of DNA containing the specific DNA-packaging motifs. Here we report a first characterization of the terminase subunits pUL56 and pUL89 of human cytomegalovirus (HCMV). Both gene products were shown to have comparable nuclease activities in vitro. Under limiting protein concentrations the nuclease activity is enhanced by interaction of pUL56 and pUL89. High amounts of 2-bromo-5,6-dichloro-1-β-d-ribofuranosyl benzimidazole partially inhibited the pUL89-associated nuclease activity. It was demonstrated that pUL56 is able to bind to nucleocapsids in vivo. Electron microscopy (EM) and image analysis of purified pUL56 revealed that the molecules occurred as a distinct ring-shaped structure with a pronounced cleft. EM analysis of purified pUL89 demonstrated that this protein is also a toroidal DNA-metabolizing protein. Upon interaction of pUL56 with linearized DNA, the DNA remains uncut while the cutting event itself is mediated by pUL89. Using biochemical assays in conjunction with EM pUL56 was shown to (i) bind to DNA and (ii) associate with the capsid. In contrast to this, EM analysis implied that pUL89 is required to effect DNA cleavage. The data provide the first insights into the terminase-dependent viral DNA-packaging mechanism of HCMV.
doi_str_mv 10.1093/nar/30.7.1695
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_101837</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71553428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-229e571bdba212576ecd6781fc506d8fb4b013fbc72cac1591cc0899f5e4d3973</originalsourceid><addsrcrecordid>eNqFkb1vFDEQxVcIRI5ASYssCrq9ePyxXhcUUQIJ0gmaRKA0ltfrvXPYtQ9_BMJfzx45JUBDNSPN7z3NzKuql4CXgCU98joeUbwUS2gkf1QtgDakZrIhj6sFppjXgFl7UD1L6RpjYMDZ0-oAQILAlCyqcrGxKNs4Oa-TRal0xbuc0PZyxRukfb_rWonCgDZl0h6Z2xwmu9ZjuHGxJKSjRacfj-vJZt2F0f10fo22MWTrfELfXd6gHGJwvR5RyrGYXKJ9Xj0Z9Jjsi309rC7fv7s4Oa9Xn84-nByvasNEm2tCpOUCur7TBAgXjTV9I1oYDMdN3w4d6zDQoTOCGG2ASzAGt1IO3LKeSkEPq7d3vtvSTbY31ueoR7WNbtLxVgXt1N8T7zZqHW4UYGjpTv9mr4_hW7Epq8klY8dRextKUgI4p4y0_wVnNyIFyBl8_Q94HUr08xMUwZi3rPkN1XeQiSGlaIf7jQGrXepqTl1RrITapT7zr_4884Hex_xg6FK2P-7nOn5VjaCCq_MvV4pcnRJ6xlbqM_0FgAO5rQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200584619</pqid></control><display><type>article</type><title>The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure</title><source>MEDLINE</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Scheffczik, Hanno ; Savva, Christos G. W. ; Holzenburg, Andreas ; Kolesnikova, Larissa ; Bogner, Elke</creator><creatorcontrib>Scheffczik, Hanno ; Savva, Christos G. W. ; Holzenburg, Andreas ; Kolesnikova, Larissa ; Bogner, Elke</creatorcontrib><description>Herpesvirus DNA packaging involves binding and cleavage of DNA containing the specific DNA-packaging motifs. Here we report a first characterization of the terminase subunits pUL56 and pUL89 of human cytomegalovirus (HCMV). Both gene products were shown to have comparable nuclease activities in vitro. Under limiting protein concentrations the nuclease activity is enhanced by interaction of pUL56 and pUL89. High amounts of 2-bromo-5,6-dichloro-1-β-d-ribofuranosyl benzimidazole partially inhibited the pUL89-associated nuclease activity. It was demonstrated that pUL56 is able to bind to nucleocapsids in vivo. Electron microscopy (EM) and image analysis of purified pUL56 revealed that the molecules occurred as a distinct ring-shaped structure with a pronounced cleft. EM analysis of purified pUL89 demonstrated that this protein is also a toroidal DNA-metabolizing protein. Upon interaction of pUL56 with linearized DNA, the DNA remains uncut while the cutting event itself is mediated by pUL89. Using biochemical assays in conjunction with EM pUL56 was shown to (i) bind to DNA and (ii) associate with the capsid. In contrast to this, EM analysis implied that pUL89 is required to effect DNA cleavage. The data provide the first insights into the terminase-dependent viral DNA-packaging mechanism of HCMV.</description><identifier>ISSN: 0305-1048</identifier><identifier>ISSN: 1362-4962</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/30.7.1695</identifier><identifier>PMID: 11917032</identifier><identifier>CODEN: NARHAD</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>2-bromo-5,6-dichloro-1-^b-D-ribofuranosyl benzimidazole ; Animals ; Antiviral Agents - pharmacology ; Benzimidazoles - pharmacology ; Capsid - metabolism ; Cell Line ; Cytomegalovirus - drug effects ; Cytomegalovirus - enzymology ; Cytomegalovirus - genetics ; Deoxyribonucleases - drug effects ; Deoxyribonucleases - metabolism ; DNA - genetics ; DNA - metabolism ; Dose-Response Relationship, Drug ; Endodeoxyribonucleases - genetics ; Endodeoxyribonucleases - metabolism ; Endodeoxyribonucleases - ultrastructure ; Human cytomegalovirus ; Microscopy, Electron ; packaging ; Protein Subunits ; Recombinant Proteins - genetics ; Recombinant Proteins - isolation &amp; purification ; Recombinant Proteins - metabolism ; Ribonucleosides - pharmacology ; terminase ; UL56 protein ; UL89 protein</subject><ispartof>Nucleic acids research, 2002-04, Vol.30 (7), p.1695-1703</ispartof><rights>Copyright Oxford University Press(England) Apr 1, 2002</rights><rights>Copyright © 2002 Oxford University Press 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-229e571bdba212576ecd6781fc506d8fb4b013fbc72cac1591cc0899f5e4d3973</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC101837/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC101837/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11917032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scheffczik, Hanno</creatorcontrib><creatorcontrib>Savva, Christos G. W.</creatorcontrib><creatorcontrib>Holzenburg, Andreas</creatorcontrib><creatorcontrib>Kolesnikova, Larissa</creatorcontrib><creatorcontrib>Bogner, Elke</creatorcontrib><title>The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure</title><title>Nucleic acids research</title><addtitle>Nucl. Acids Res</addtitle><description>Herpesvirus DNA packaging involves binding and cleavage of DNA containing the specific DNA-packaging motifs. Here we report a first characterization of the terminase subunits pUL56 and pUL89 of human cytomegalovirus (HCMV). Both gene products were shown to have comparable nuclease activities in vitro. Under limiting protein concentrations the nuclease activity is enhanced by interaction of pUL56 and pUL89. High amounts of 2-bromo-5,6-dichloro-1-β-d-ribofuranosyl benzimidazole partially inhibited the pUL89-associated nuclease activity. It was demonstrated that pUL56 is able to bind to nucleocapsids in vivo. Electron microscopy (EM) and image analysis of purified pUL56 revealed that the molecules occurred as a distinct ring-shaped structure with a pronounced cleft. EM analysis of purified pUL89 demonstrated that this protein is also a toroidal DNA-metabolizing protein. Upon interaction of pUL56 with linearized DNA, the DNA remains uncut while the cutting event itself is mediated by pUL89. Using biochemical assays in conjunction with EM pUL56 was shown to (i) bind to DNA and (ii) associate with the capsid. In contrast to this, EM analysis implied that pUL89 is required to effect DNA cleavage. The data provide the first insights into the terminase-dependent viral DNA-packaging mechanism of HCMV.</description><subject>2-bromo-5,6-dichloro-1-^b-D-ribofuranosyl benzimidazole</subject><subject>Animals</subject><subject>Antiviral Agents - pharmacology</subject><subject>Benzimidazoles - pharmacology</subject><subject>Capsid - metabolism</subject><subject>Cell Line</subject><subject>Cytomegalovirus - drug effects</subject><subject>Cytomegalovirus - enzymology</subject><subject>Cytomegalovirus - genetics</subject><subject>Deoxyribonucleases - drug effects</subject><subject>Deoxyribonucleases - metabolism</subject><subject>DNA - genetics</subject><subject>DNA - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endodeoxyribonucleases - genetics</subject><subject>Endodeoxyribonucleases - metabolism</subject><subject>Endodeoxyribonucleases - ultrastructure</subject><subject>Human cytomegalovirus</subject><subject>Microscopy, Electron</subject><subject>packaging</subject><subject>Protein Subunits</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - isolation &amp; purification</subject><subject>Recombinant Proteins - metabolism</subject><subject>Ribonucleosides - pharmacology</subject><subject>terminase</subject><subject>UL56 protein</subject><subject>UL89 protein</subject><issn>0305-1048</issn><issn>1362-4962</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1vFDEQxVcIRI5ASYssCrq9ePyxXhcUUQIJ0gmaRKA0ltfrvXPYtQ9_BMJfzx45JUBDNSPN7z3NzKuql4CXgCU98joeUbwUS2gkf1QtgDakZrIhj6sFppjXgFl7UD1L6RpjYMDZ0-oAQILAlCyqcrGxKNs4Oa-TRal0xbuc0PZyxRukfb_rWonCgDZl0h6Z2xwmu9ZjuHGxJKSjRacfj-vJZt2F0f10fo22MWTrfELfXd6gHGJwvR5RyrGYXKJ9Xj0Z9Jjsi309rC7fv7s4Oa9Xn84-nByvasNEm2tCpOUCur7TBAgXjTV9I1oYDMdN3w4d6zDQoTOCGG2ASzAGt1IO3LKeSkEPq7d3vtvSTbY31ueoR7WNbtLxVgXt1N8T7zZqHW4UYGjpTv9mr4_hW7Epq8klY8dRextKUgI4p4y0_wVnNyIFyBl8_Q94HUr08xMUwZi3rPkN1XeQiSGlaIf7jQGrXepqTl1RrITapT7zr_4884Hex_xg6FK2P-7nOn5VjaCCq_MvV4pcnRJ6xlbqM_0FgAO5rQ</recordid><startdate>20020401</startdate><enddate>20020401</enddate><creator>Scheffczik, Hanno</creator><creator>Savva, Christos G. W.</creator><creator>Holzenburg, Andreas</creator><creator>Kolesnikova, Larissa</creator><creator>Bogner, Elke</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20020401</creationdate><title>The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure</title><author>Scheffczik, Hanno ; Savva, Christos G. W. ; Holzenburg, Andreas ; Kolesnikova, Larissa ; Bogner, Elke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-229e571bdba212576ecd6781fc506d8fb4b013fbc72cac1591cc0899f5e4d3973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>2-bromo-5,6-dichloro-1-^b-D-ribofuranosyl benzimidazole</topic><topic>Animals</topic><topic>Antiviral Agents - pharmacology</topic><topic>Benzimidazoles - pharmacology</topic><topic>Capsid - metabolism</topic><topic>Cell Line</topic><topic>Cytomegalovirus - drug effects</topic><topic>Cytomegalovirus - enzymology</topic><topic>Cytomegalovirus - genetics</topic><topic>Deoxyribonucleases - drug effects</topic><topic>Deoxyribonucleases - metabolism</topic><topic>DNA - genetics</topic><topic>DNA - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endodeoxyribonucleases - genetics</topic><topic>Endodeoxyribonucleases - metabolism</topic><topic>Endodeoxyribonucleases - ultrastructure</topic><topic>Human cytomegalovirus</topic><topic>Microscopy, Electron</topic><topic>packaging</topic><topic>Protein Subunits</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - isolation &amp; purification</topic><topic>Recombinant Proteins - metabolism</topic><topic>Ribonucleosides - pharmacology</topic><topic>terminase</topic><topic>UL56 protein</topic><topic>UL89 protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scheffczik, Hanno</creatorcontrib><creatorcontrib>Savva, Christos G. W.</creatorcontrib><creatorcontrib>Holzenburg, Andreas</creatorcontrib><creatorcontrib>Kolesnikova, Larissa</creatorcontrib><creatorcontrib>Bogner, Elke</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scheffczik, Hanno</au><au>Savva, Christos G. W.</au><au>Holzenburg, Andreas</au><au>Kolesnikova, Larissa</au><au>Bogner, Elke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucl. Acids Res</addtitle><date>2002-04-01</date><risdate>2002</risdate><volume>30</volume><issue>7</issue><spage>1695</spage><epage>1703</epage><pages>1695-1703</pages><issn>0305-1048</issn><issn>1362-4962</issn><eissn>1362-4962</eissn><coden>NARHAD</coden><abstract>Herpesvirus DNA packaging involves binding and cleavage of DNA containing the specific DNA-packaging motifs. Here we report a first characterization of the terminase subunits pUL56 and pUL89 of human cytomegalovirus (HCMV). Both gene products were shown to have comparable nuclease activities in vitro. Under limiting protein concentrations the nuclease activity is enhanced by interaction of pUL56 and pUL89. High amounts of 2-bromo-5,6-dichloro-1-β-d-ribofuranosyl benzimidazole partially inhibited the pUL89-associated nuclease activity. It was demonstrated that pUL56 is able to bind to nucleocapsids in vivo. Electron microscopy (EM) and image analysis of purified pUL56 revealed that the molecules occurred as a distinct ring-shaped structure with a pronounced cleft. EM analysis of purified pUL89 demonstrated that this protein is also a toroidal DNA-metabolizing protein. Upon interaction of pUL56 with linearized DNA, the DNA remains uncut while the cutting event itself is mediated by pUL89. Using biochemical assays in conjunction with EM pUL56 was shown to (i) bind to DNA and (ii) associate with the capsid. In contrast to this, EM analysis implied that pUL89 is required to effect DNA cleavage. The data provide the first insights into the terminase-dependent viral DNA-packaging mechanism of HCMV.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>11917032</pmid><doi>10.1093/nar/30.7.1695</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-1048
ispartof Nucleic acids research, 2002-04, Vol.30 (7), p.1695-1703
issn 0305-1048
1362-4962
1362-4962
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_101837
source MEDLINE; Oxford Journals Open Access Collection; PubMed Central; Free Full-Text Journals in Chemistry
subjects 2-bromo-5,6-dichloro-1-^b-D-ribofuranosyl benzimidazole
Animals
Antiviral Agents - pharmacology
Benzimidazoles - pharmacology
Capsid - metabolism
Cell Line
Cytomegalovirus - drug effects
Cytomegalovirus - enzymology
Cytomegalovirus - genetics
Deoxyribonucleases - drug effects
Deoxyribonucleases - metabolism
DNA - genetics
DNA - metabolism
Dose-Response Relationship, Drug
Endodeoxyribonucleases - genetics
Endodeoxyribonucleases - metabolism
Endodeoxyribonucleases - ultrastructure
Human cytomegalovirus
Microscopy, Electron
packaging
Protein Subunits
Recombinant Proteins - genetics
Recombinant Proteins - isolation & purification
Recombinant Proteins - metabolism
Ribonucleosides - pharmacology
terminase
UL56 protein
UL89 protein
title The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A49%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20terminase%20subunits%20pUL56%20and%20pUL89%20of%20human%20cytomegalovirus%20are%20DNA-metabolizing%20proteins%20with%20toroidal%20structure&rft.jtitle=Nucleic%20acids%20research&rft.au=Scheffczik,%20Hanno&rft.date=2002-04-01&rft.volume=30&rft.issue=7&rft.spage=1695&rft.epage=1703&rft.pages=1695-1703&rft.issn=0305-1048&rft.eissn=1362-4962&rft.coden=NARHAD&rft_id=info:doi/10.1093/nar/30.7.1695&rft_dat=%3Cproquest_pubme%3E71553428%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200584619&rft_id=info:pmid/11917032&rfr_iscdi=true